December 9, 2021
FDA: Edge Pharma issues nationwide recall of all drug products
Editor's Note
The Food and Drug Administration (FDA) on December 7 announced that Edge Pharma, LLC (Colchester, Vermont) has issued a nationwide recall of all drug products.
The recall was initiated because of process issues that could lead to a lack of sterility assurance for products intended to be sterile and could affect the safety and quality of nonsterile products.
To date, Edge Pharma has not received and is not aware of any adverse events related to this recall.
Free Daily News
- FDA issues Class I alert for Abiomed Impella heart device over cybersecurity risks
- Study finds Medicare paid nearly $2 billion for unnecessary back surgeries
- FDA accelerates medical device safety alerts to reach public within days
- California’s worsening nurse shortage fuels burnout, safety concerns amid management tensions
- AI is turning medical devices into learning systems, Google Cloud exec says
- Tray-based setups cut OR waste, setup time while boosting workflow satisfaction
- OR Manager Conference delivers ready-to-use solutions for perioperative leaders
- The Joint Commission set to spotlight hospitals’ strengths with new SAFEST initiative
- FDA has begun requiring electronic De Novo submissions for new medical devices
- Spine surgeon shortage deepens as consolidation, site shifts reshape ASC markets
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement